Literature DB >> 30190983

Immune play: defending the liver.

Geraldine O'Sullivan Coyne1,1, Tim F Greten2,2.   

Abstract

Keywords:  abscopal effect; checkpoint inhibitor; hepatocellular carcinoma; immunotherapy; tumor cell death

Year:  2015        PMID： 30190983      PMCID： PMC6095429          DOI： 10.2217/hep.14.35

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


× No keyword cloud information.
  20 in total

1.  Radiofrequency ablation for the treatment of HCC--maybe much more than simple tumor destruction?

Authors:  Tim F Greten; Firouzeh Korangy
Journal:  J Hepatol       Date:  2010-06-20       Impact factor: 25.083

2.  Abscopal effect on hepatocellular carcinoma.

Authors:  Mitsuru Nakanishi; Makoto Chuma; Shuhei Hige; Masahiro Asaka
Journal:  Am J Gastroenterol       Date:  2008-05       Impact factor: 10.864

3.  Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis.

Authors:  K Ohba; K Omagari; T Nakamura; N Ikuno; S Saeki; I Matsuo; H Kinoshita; J Masuda; H Hazama; I Sakamoto; S Kohno
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

Review 4.  The blockade of immune checkpoints in cancer immunotherapy.

Authors:  Drew M Pardoll
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

5.  Induction of immunological tolerance by porcine liver allografts.

Authors:  R Y Calne; R A Sells; J R Pena; D R Davis; P R Millard; B M Herbertson; R M Binns; D A Davies
Journal:  Nature       Date:  1969-08-02       Impact factor: 49.962

Review 6.  Cancer immunotherapy comes of age.

Authors:  Suzanne L Topalian; George J Weiner; Drew M Pardoll
Journal:  J Clin Oncol       Date:  2011-10-31       Impact factor: 44.544

7.  Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells.

Authors:  Birgit Jürgens; Ursula Hainz; Dietmar Fuchs; Thomas Felzmann; Andreas Heitger
Journal:  Blood       Date:  2009-07-22       Impact factor: 22.113

Review 8.  Tumor antigens recognized by T lymphocytes.

Authors:  T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 9.  Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment.

Authors:  Thomas F Gajewski; Seng-Ryong Woo; Yuanyuan Zha; Robbert Spaapen; Yan Zheng; Leticia Corrales; Stefani Spranger
Journal:  Curr Opin Immunol       Date:  2013-04-08       Impact factor: 7.486

10.  Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma.

Authors:  Tobias Flecken; Nathalie Schmidt; Sandra Hild; Emma Gostick; Oliver Drognitz; Robert Zeiser; Peter Schemmer; Helge Bruns; Thomas Eiermann; David A Price; Hubert E Blum; Christoph Neumann-Haefelin; Robert Thimme
Journal:  Hepatology       Date:  2014-02-20       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.